Brain+ A/S (CPH: BRAINP)
Denmark
· Delayed Price · Currency is DKK 0.0800
-0.0144 (-15.25%)
Dec 20, 2024, 4:52 PM CET
Brain+ Market Cap
Brain+ has a market cap or net worth of 17.00 million as of December 20, 2024. Its market cap has increased by 27.32% in one year.
Market Cap
17.00M
Enterprise Value
n/a
Revenue
6.08M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.08
Market Cap Chart
Since October 7, 2021, Brain+'s market cap has decreased from 51.99M to 17.00M, a decrease of -67.30%. That is a compound annual growth rate of -29.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 17.00M | 33.89% |
| Dec 29, 2023 | 12.70M | -37.15% |
| Dec 30, 2022 | 20.21M | -50.00% |
| Dec 30, 2021 | 40.41M | -22.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk A/S | 3,288.15B |
| Coloplast A/S | 177.95B |
| Genmab A/S | 92.36B |
| Zealand Pharma A/S | 56.69B |
| Demant A/S | 56.34B |
| H. Lundbeck A/S | 38.79B |
| H. Lundbeck A/S | 38.79B |
| ALK-Abelló A/S | 35.72B |